A diet supplemented with flaxseed, rich in α-linolenic acid and plant lignans (the latter, potent platelet-activating factor receptor antagonists), was tested in a murine model of lupus nephritis. MRL/lpr female mice (n = 25) were fed 15% flaxseed diet for 14 weeks commencing at 10 weeks of age. As controls, 30 MRL/lpr mice received a standard rodent diet without flaxseed. Isotope-glomerular filtration rate (14C-inulin clearance) was measured at 9, 16, and 24 weeks of age. Proteinuria was assessed at 2-week intervals. Spleen lymphocyte proliferation, quantitated by DNA analysis, was evaluated using flow cytometry at 9, 13, 19, and 21 weeks of age. Mortality was recorded throughout the study. Glomerular filtration rate at 16 weeks was greater in flaxseed-fed mice (0.15 ± 0.03 mL/min) compared with controls (0.06 ± 0.04 mL/min; P = 0.01). The onset of proteinuria (Albustix, Ames Division, Miles Laboratories, Rexdale, Ontario, Canada; ≥2+) was delayed by 4 weeks in the flax-treated mice. The percentage of flaxseed-fed mice with proteinuria was lower than the control mice up to 21 weeks of age (39% v 58%; P = 0.01). Spleen lymphocyte proliferation (percentage of cells in S-phase) at 13 weeks of age was significantly higher in the control group (22.9 ± 5.0, P = 0.01) but not in the flaxseed group (17.2 ± 4.9) compared with baseline (9 weeks of age) values (13.0 ± 3.5). Mortality was lower in the flaxseed-fed mice versus the control mice (assessed by Mantel-Haenszel (log-rank) test; P < 0.05). Dietary flaxseed attenuated both the decline in glomerular filtration rate and lymphoproliferation, and reduced proteinuria and mortality in MRL/lpr mice. Anti-inflammatory, antiproliferative, and immunoregulatory properties of flaxseed, a rich source of α-linolenic acid and lignans, provide a rationale for evaluating the mechanisms of action of flaxseed and its constituents in experimental and human immune renal diseases. © 1993, National Kidney Foundation, Inc.. All rights reserved.